Filter by
Filter by
CNS & Leptomeningeal Disease
Minesh Mehta covers three indications that are very promising for proton therapy: leptomeningeal disease, low-grade glioma, and glioblastoma. Watch the talk's...
Hypofractionation in Proton Therapy: radiobiological bases and clinical applications
The use of hypofractionated schedules in proton therapy is rapidly increasing. Their application has several advantages, including the reduction of overall...
Proton beam radiation therapy for vestibular schwannomas – tumor control and hearing preservation rates: a systematic review and meta-analysis.
This meta-analysis included 8 primary studies with a total number of 587 patients with vestibular schwannomas treated with proton radiation. Overall rate of...
Hypofractionated proton therapy for benign tumors of the central nervous system: A systematic review of the literature.
This systematic review summarized results of the literature in the setting of patients treated with hypofractionated PT for benign lesions of the central...
High-dose proton beam therapy versus conventional fractionated radiation therapy for newly diagnosed glioblastoma: a propensity score matching analysis.
This study compared the survival outcomes and toxicities of high-dose PBT of 96.6 GyRBE and CRT of 60 Gy using propensity score-matched treatment cohorts. From...